Glaucoma is an optic neuropathy that is characterized by the progressive degeneration of
the optic nerve, leading to visual impairment. Glaucoma is the main cause of irreversible …

Over the last two decades, a large number of non-communicable/chronic disorders reached
an epidemic level on a global scale such as diabetes mellitus type 2, cardio-vascular …

Glaucoma is the most prevalent neurodegenerative disease and a leading cause of
blindness worldwide. The mechanisms causing glaucomatous neurodegeneration are not …

Neurodegenerative diseases are characterized by the loss of neurons and/or myelin sheath,
which deteriorate over time and cause dysfunction. Interleukin 17A is the signature cytokine …

For many retinal diseases, including age-related macular degeneration (AMD), glaucoma,
and diabetic retinopathy (DR), the exact pathogenesis is still unclear. Moreover, the currently …

Glaucoma is the leading cause of irreversible blindness. Currently, most therapeutic
strategies aim to reduce elevated intraocular pressure (EIOP), but this does not always halt …

Purpose To analyse intraocular cytokine levels and prevalence of intraocular antiretinal
antibodies (ARA s) in patients with retinitis pigmentosa (RP), age‐related macular …

The cholinergic system has a crucial role to play in visual function. Although cholinergic
drugs have been a focus of attention as glaucoma medications for reducing eye pressure …

The main focus in clinical proteomics is the discovery of new protein or peptide biomarkers
which are correlated with a certain disease. Tear proteins have been investigated …

Primary open-angle glaucoma (POAG) is the second leading cause of irreversible blindness
worldwide. Increasing evidence suggests oxidative damage and immune response defects …